Tag Archives | HIV therapy

Biotechs Bounce From Support Levels Despite Mixed Earnings Reports…Update 5/3- Testing 2018 Lows

hop over to this website 5/3 Testing February bottom and 200 MA of ~$100 on IBB and ~$85 on XBI. Red screen day. 2PM EDT Dow near flat line. Need to look for major gap up. Another potential negative on the horizon: “Bold Action on Drug Pricing” by Sect’y HHS. 5/2 ¬†Biotech Stocks Are About To Test 2018 Lows: It […]

Continue Reading 0

Biotechs Buffeted by Macro News But Should Continue to Outperform…Update-1

buy modafinil online overnight Update-1 March 10… Broad Rally Continues Through The Week QQQ Up 4.3% IBB up 4.3% XBI up 4.8% Gene Editing Stocks Surge Biotech stocks soared along with the market as fear about interest rates, tariffs and global politics subsided helped considerably by economic sentiment and jobs. Moreover the employment report showed wage gains revised downward […]

Continue Reading 0

Gilead(GILD) and Abbott(ABT) Guidance Triggers Biotech Sell-Off

Discover More Here Healthcare Reform Impact on Gilead HIV Product Sales Surprises Analysts Gilead Sciences (GILD) lowered its 2010 sales forecast to a range of $7.4-$7.5B from $7.6-$7.8B citing recently enacted healthcare legislation. Net income for the quarter ended March 31 jumped from $854.9M or $0.92/sh. compared with $589.1M or $0.63/sh. in the Year ago period. Gilead’s first-quarter […]

Continue Reading 0